{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:46:39Z","timestamp":1794545199777,"version":"4.9.1"},"reference-count":143,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province, China","doi-asserted-by":"publisher","award":["ZR2020MH305"],"award-info":[{"award-number":["ZR2020MH305"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019446","name":"Medical and Health Science and Technology Development Program of Shandong Province, China","doi-asserted-by":"publisher","award":["2019WS593"],"award-info":[{"award-number":["2019WS593"]}],"id":[{"id":"10.13039\/501100019446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>The high global burden of tuberculosis (TB) and the increasing emergence of the drugresistant\n(DR) strain of Mycobacterium tuberculosis (Mtb) emphasize the urgent need for novel antimycobacterial\nagents. Antimicrobial peptides (AMPs) are small peptides widely existing in a variety\nof organisms and usually have amphiphilic cationic structures, which have a selective affinity to the\nnegatively charged bacterial cell wall. Besides direct bactericidal mechanisms, including interacting\nwith the bacterial cell membrane and interfering with the biosynthesis of the cell wall, DNA, or\nprotein, some AMPs are involved in the host's innate immunity. AMPs are promising alternative or\ncomplementary agents for the treatment of DR-TB, given their various antibacterial mechanisms and\nlow cytotoxicity. A large number of AMPs, synthetic or natural, from human to bacteriophage\nsources, have displayed potent anti-mycobacterial activity in vitro and in vivo. In this review, we\nsummarized the features, antimycobacterial activity, and mechanisms of action of the AMPs according\nto their sources. Although AMPs have not yet met the expectations for clinical application due to their\nlow bioavailabilities, high cost, and difficulties in large-scale production, their potent\nantimycobacterial activity and action mechanisms, which are different from conventional antibiotics,\nmake them promising antibacterial agents against DR-Mtb in the future.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929866530666230315113624","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T04:24:57Z","timestamp":1678940697000},"page":"280-294","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Antimicrobial Peptides: A Promising Strategy for Anti-tuberculosis\nTherapeutics"],"prefix":"10.2174","volume":"30","author":[{"given":"Yu","family":"Ning","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, Weifang Medical University, Weifang, Shandong, 261053, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, Weifang Medical University, Weifang, Shandong, 261053, P.R. China"},{"name":"Institutional Key Laboratory of Clinical Laboratory Diagnostics, 12th 5-Year Project of Shandong Province, Weifang\nMedical University, Weifang, Shandong, 261053, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, Weifang Medical University, Weifang, Shandong, 261053, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangying","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, Weifang Medical University, Weifang, Shandong, 261053, P.R. China"},{"name":"Institutional Key Laboratory of Clinical Laboratory Diagnostics, 12th 5-Year Project of Shandong Province, Weifang\nMedical University, Weifang, Shandong, 261053, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjuan","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, Weifang Medical University, Weifang, Shandong, 261053, P.R. China"},{"name":"Institutional Key Laboratory of Clinical Laboratory Diagnostics, 12th 5-Year Project of Shandong Province, Weifang\nMedical University, Weifang, Shandong, 261053, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","year":"2022","unstructured":"World Health Organization (WHO) Global tuberculosis report Available from: 2022","journal-title":"Global tuberculosis report"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/sji.12160","volume":"79","author":"Zhang W.","year":"2014","unstructured":"Zhang W.; Jiang H.; Bai Y.; Kang J.; Xu Z.K.; Wang L.M.; Construction and immunogenicity of the DNA vaccine of Mycobacterium tuberculosis dormancy antigen rv1733c. Scand J Immunol 2014,79(5),292-298","journal-title":"Scand J Immunol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/nbt1267","volume":"24","author":"Hancock R.E.W.","year":"2006","unstructured":"Hancock R.E.W.; Sahl H.G.; Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 2006,24(12),1551-1557","journal-title":"Nat Biotechnol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3390\/ph6081055","volume":"6","author":"Aoki W.","year":"2013","unstructured":"Aoki W.; Ueda M.; Characterization of antimicrobial peptides toward the development of novel antibiotics. Pharmaceuticals 2013,6(8),1055-1081","journal-title":"Pharmaceuticals"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3389\/fimmu.2017.01499","volume":"8","author":"Arranz-Trullen J.","year":"2017","unstructured":"Arranz-Trullen J.; Lu L.; Pulido D.; Bhakta S.; Boix E.; Host antimicrobial peptides: The promise of new treatment strategies against tuberculosis. Front Immunol 2017,8,1499","journal-title":"Front Immunol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"7615","DOI":"10.1074\/jbc.RA118.006968","volume":"294","author":"Yang Y.","year":"2019","unstructured":"Yang Y.; Liu Z.; He X.; Yang J.; Wu J.; Yang H.; Li M.; Qian Q.; Lai R.; Xu W.; Wei L.; A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities. J Biol Chem 2019,294(19),7615-7631","journal-title":"J Biol Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1182\/blood.V97.12.3951","volume":"97","author":"S&#xF8;rensen O.E.","year":"2001","unstructured":"S&#xF8;rensen O.E.; Follin P.; Johnsen A.H.; Calafat J.; Tjabringa G.S.; Hiemstra P.S.; Borregaard N.; Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 2001,97(12),3951-3959","journal-title":"Blood"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijantimicag.2012.09.015","volume":"41","author":"Rivas-Santiago B.","year":"2013","unstructured":"Rivas-Santiago B.; Rivas Santiago C.E.; Casta&#xF1;eda-Delgado J.E.; Le&#xF3;n-Contreras J.C.; Hancock R.E.W.; Hernandez-Pando R.; Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis. Int J Antimicrob Agents 2013,41(2),143-148","journal-title":"Int J Antimicrob Agents"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1074\/jbc.273.6.3718","volume":"273","author":"Johansson J.","year":"1998","unstructured":"Johansson J.; Gudmundsson G.H.; Rottenberg M.E.; Berndt K.D.; Agerberth B.; Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 1998,273(6),3718-3724","journal-title":"J Biol Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/0-306-46831-X_17","volume":"479","author":"Zanetti M.","year":"2000","unstructured":"Zanetti M.; Gennaro R.; Scocchi M.; Skerlavaj B.; Structure and biology of cathelicidins. Adv Exp Med Biol 2000,479,203-218","journal-title":"Adv Exp Med Biol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000336630","volume":"4","author":"Choi K.Y.","year":"2012","unstructured":"Choi K.Y.; Chow L.N.Y.; Mookherjee N.; Cationic host defence peptides: Multifaceted role in immune modulation and inflammation. J Innate Immun 2012,4(4),361-370","journal-title":"J Innate Immun"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00441-010-1022-4","volume":"343","author":"Hazlett L.","year":"2011","unstructured":"Hazlett L.; Wu M.; Defensins in innate immunity. Cell Tissue Res 2011,343(1),175-188","journal-title":"Cell Tissue Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1034\/j.1399-3003.2000.16a20.x","volume":"16","author":"Sharma S.","year":"2000","unstructured":"Sharma S.; Verma I.; Khuller G.; Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37Rv: In vitro and ex vivo study. Eur Respir J 2000,16(1),112-117","journal-title":"Eur Respir J"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s002030050719","volume":"171","author":"Sharma S.","year":"1999","unstructured":"Sharma S.; Verma I.; Khuller G.K.; Biochemical interaction of human neutrophil peptide-1 with Mycobacterium tuberculosis H37 Ra. Arch Microbiol 1999,171(5),338-342","journal-title":"Arch Microbiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"e02340","DOI":"10.1128\/AAC.02340-16","volume":"61","author":"Le C.F.","year":"2017","unstructured":"Le C.F.; Fang C.M.; Sekaran S.D.; Intracellular targeting mechanisms by antimicrobial peptides. Antimicrob Agents Chemother 2017,61(4),e02340-e16","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s002840010263","volume":"43","author":"Sharma S.","year":"2001","unstructured":"Sharma S.; Khuller G.K.; DNA as the intracellular secondary target for antibacterial action of human neutrophil peptide-I against Mycobacterium tuberculosis H37Ra. Curr Microbiol 2001,43(1),74-76","journal-title":"Curr Microbiol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.1128\/IAI.70.8.4591-4599.2002","volume":"70","author":"Kisich K.O.","year":"2002","unstructured":"Kisich K.O.; Higgins M.; Diamond G.; Heifets L.; Tumor necrosis factor alpha stimulates killing of Mycobacterium tuberculosis by human neutrophils. Infect Immun 2002,70(8),4591-4599","journal-title":"Infect Immun"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1172\/JCI2410","volume":"102","author":"Bals R.","year":"1998","unstructured":"Bals R.; Wang X.; Wu Z.; Freeman T.; Bafna V.; Zasloff M.; Wilson J.M.; Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 1998,102(5),874-880","journal-title":"J Clin Invest"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1067\/mai.2002.129801","volume":"110","author":"Gallo R.L.","year":"2002","unstructured":"Gallo R.L.; Murakami M.; Ohtake T.; Zaiou M.; Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol 2002,110(6),823-831","journal-title":"J Allergy Clin Immunol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pep.2013.02.007","volume":"89","author":"Corrales-Garcia L.","year":"2013","unstructured":"Corrales-Garcia L.; Ortiz E.; Casta&#xF1;eda-Delgado J.; Rivas-Santiago B.; Corzo G.; Bacterial expression and antibiotic activities of recombinant variants of human-defensins on pathogenic bacteria and M. tuberculosis. Protein Expr Purif 2013,89(1),33-43","journal-title":"Protein Expr Purif"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"48671","DOI":"10.1074\/jbc.M404690200","volume":"279","author":"Campopiano D.J.","year":"2004","unstructured":"Campopiano D.J.; Clarke D.J.; Polfer N.C.; Barran P.E.; Langley R.J.; Govan J.R.W.; Maxwell A.; Dorin J.R.; Structure-activity relationships in defensin dimers: A novel link between beta-defensin tertiary structure and antimicrobial activity. J Biol Chem 2004,279(47),48671-48679","journal-title":"J Biol Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.4049\/jimmunol.158.6.2680","volume":"158","author":"Pe&#xF1;a S.V.","year":"1997","unstructured":"Pe&#xF1;a S.V.; Hanson D.A.; Carr B.A.; Goralski T.J.; Krensky A.M.; Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J Immunol 1997,158(6),2680-2688","journal-title":"J Immunol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1126\/science.282.5386.121","volume":"282","author":"Stenger S.","year":"1998","unstructured":"Stenger S.; Hanson D.A.; Teitelbaum R.; Dewan P.; Niazi K.R.; Froelich C.J.; Ganz T.; Thoma-Uszynski S.; Meli&#xE1;n A.; Bogdan C.; Porcelli S.A.; Bloom B.R.; Krensky A.M.; Modlin R.L.; An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998,282(5386),121-125","journal-title":"Science"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.cell.2014.03.062","volume":"157","author":"Walch M.","year":"2014","unstructured":"Walch M.; Dotiwala F.; Mulik S.; Thiery J.; Kirchhausen T.; Clayberger C.; Krensky A.M.; Martinvalet D.; Lieberman J.; Cytotoxic cells kill intracellular bacteria through granulysin-mediated delivery of granzymes. Cell 2014,157(6),1309-1323","journal-title":"Cell"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.4049\/jimmunol.174.9.5243","volume":"174","author":"Deng A.","year":"2005","unstructured":"Deng A.; Chen S.; Li Q.; Lyu S.; Clayberger C.; Krensky A.M.; Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator. J Immunol 2005,174(9),5243-5248","journal-title":"J Immunol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"7806","DOI":"10.1074\/jbc.M008922200","volume":"276","author":"Park C.H.","year":"2001","unstructured":"Park C.H.; Valore E.V.; Waring A.J.; Ganz T.; Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001,276(11),7806-7810","journal-title":"J Biol Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1189\/jlb.0407216","volume":"82","author":"Sow F.B.","year":"2007","unstructured":"Sow F.B.; Florence W.C.; Satoskar A.R.; Schlesinger L.S.; Zwilling B.S.; Lafuse W.P.; Expression and localization of hepcidin in macrophages: A role in host defense against tuberculosis. J Leukoc Biol 2007,82(4),934-945","journal-title":"J Leukoc Biol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"9922","DOI":"10.1021\/bi301426j","volume":"51","author":"Foss M.H.","year":"2012","unstructured":"Foss M.H.; Powers K.M.; Purdy G.E.; Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes. Biochemistry 2012,51(49),9922-9929","journal-title":"Biochemistry"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/j.1365-2958.2009.06801.x","volume":"73","author":"Purdy G.E.","year":"2009","unstructured":"Purdy G.E.; Niederweis M.; Russell D.G.; Decreased outer membrane permeability protects mycobacteria from killing by ubiquitin-derived peptides. Mol Microbiol 2009,73(5),844-857","journal-title":"Mol Microbiol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.4049\/jimmunol.179.4.2634","volume":"179","author":"Monteseir&#xED;n J.","year":"2007","unstructured":"Monteseir&#xED;n J.; Vega A.; Chac&#xF3;n P.; Camacho M.J.; El Bekay R.; Asturias J.A.; Mart&#xED;nez A.; Guardia P.; P&#xE9;rez-Cano R.; Conde J.; Neutrophils as a novel source of eosinophil cationic protein in IgE-mediated processes. J Immunol 2007,179(4),2634-2641","journal-title":"J Immunol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1046\/j.1365-2222.1999.00542.x","volume":"29","author":"Venge P.","year":"1999","unstructured":"Venge P.; Bystr&#xF6;m J.; Carlson M.; H&#xE5;kansson L.; Karawacjzyk M.; Peterson C.; Sev&#xE9;us L.; Trulson A.; Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 1999,29(9),1172-1186","journal-title":"Clin Exp Allergy"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1128\/AAC.00428-13","volume":"57","author":"Pulido D.","year":"2013","unstructured":"Pulido D.; Torrent M.; Andreu D.; Nogu&#xE9;s M.V.; Boix E.; Two human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7. Antimicrob Agents Chemother 2013,57(8),3797-3805","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.bbamem.2009.01.013","volume":"1788","author":"Torrent M.","year":"2009","unstructured":"Torrent M.; S&#xE1;nchez D.; Buz&#xF3;n V.; Nogu&#xE9;s M.V.; Cladera J.; Boix E.; Comparison of the membrane interaction mechanism of two antimicrobial RNases: RNase 3\/ECP and RNase 7. Biochim Biophys Acta Biomembr 2009,1788(5),1116-1125","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3389\/fimmu.2019.01500","volume":"10","author":"Lu L.","year":"2019","unstructured":"Lu L.; Arranz-Trullen J.; Prats-Ejarque G.; Pulido D.; Bhakta S.; Boix E.; Human antimicrobial RNases inhibit intracellular bacterial growth and induce autophagy in mycobacteria-infected macrophages. Front Immunol 2019,10,1500","journal-title":"Front Immunol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3389\/fimmu.2018.01012","volume":"9","author":"Lu L.","year":"2018","unstructured":"Lu L.; Li J.; Moussaoui M.; Boix E.; Immune modulation by human secreted RNases at the extracellular space. Front Immunol 2018,9,1012","journal-title":"Front Immunol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"46779","DOI":"10.1074\/jbc.M207587200","volume":"277","author":"Harder J.","year":"2002","unstructured":"Harder J.; Schr&#xF6;der J.M.; RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem 2002,277(48),46779-46784","journal-title":"J Biol Chem"},{"key":"ref=37","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/fty005","volume":"76","author":"Torres-Juarez F.","year":"2018","unstructured":"Torres-Juarez F.; Touqui L.; Leon-Contreras J.; Rivas-Santiago C.; Enciso-Moreno J.A.; Hern&#xE1;ndez-Pando R.; Rivas-Santiago B.; RNase 7 but not psoriasin nor sPLA2-IIA associates with Mycobacterium tuberculosis during airway epithelial cell infection. Pathog Dis 2018,76(2)","journal-title":"Pathog Dis"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/j.peptides.2010.06.016","volume":"31","author":"M&#xE9;ndez-Samperio P.","year":"2010","unstructured":"M&#xE9;ndez-Samperio P.; The human cathelicidin hCAP18\/LL-37: A multifunctional peptide involved in mycobacterial infections. Peptides 2010,31(9),1791-1798","journal-title":"Peptides"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"5788","DOI":"10.4049\/jimmunol.0901491","volume":"183","author":"Nijnik A.","year":"2009","unstructured":"Nijnik A.; Pistolic J.; Wyatt A.; Tam S.; Hancock R.E.W.; Human cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs. J Immunol 2009,183(9),5788-5798","journal-title":"J Immunol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1126\/science.1123933","volume":"311","author":"Liu P.T.","year":"2006","unstructured":"Liu P.T.; Stenger S.; Li H.; Wenzel L.; Tan B.H.; Krutzik S.R.; Ochoa M.T.; Schauber J.; Wu K.; Meinken C.; Kamen D.L.; Wagner M.; Bals R.; Steinmeyer A.; Z&#xFC;gel U.; Gallo R.L.; Eisenberg D.; Hewison M.; Hollis B.W.; Adams J.S.; Bloom B.R.; Modlin R.L.; Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006,311(5768),1770-1773","journal-title":"Science"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.chom.2009.08.004","volume":"6","author":"Yuk J.M.","year":"2009","unstructured":"Yuk J.M.; Shin D.M.; Lee H.M.; Yang C.S.; Jin H.S.; Kim K.K.; Lee Z.W.; Lee S.H.; Kim J.M.; Jo E.K.; Vitamin D3 induces autophagy in human monocytes\/macrophages via cathelicidin. Cell Host Microbe 2009,6(3),231-243","journal-title":"Cell Host Microbe"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1080\/15548627.2015.1075110","volume":"11","author":"Rekha R.S.","year":"2015","unstructured":"Rekha R.S.; Rao Muvva S.S.V.J.; Wan M.; Raqib R.; Bergman P.; Brighenti S.; Gudmundsson G.H.; Agerberth B.; Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing of Mycobacterium tuberculosis in human macrophages. Autophagy 2015,11(9),1688-1699","journal-title":"Autophagy"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1128\/IAI.00936-15","volume":"83","author":"Torres-Juarez F.","year":"2015","unstructured":"Torres-Juarez F.; Cardenas-Vargas A.; Montoya-Rosales A.; Gonz&#xE1;lez-Curiel I.; Garcia-Hernandez M.H.; Enciso-Moreno J.A.; Hancock R.E.W.; Rivas-Santiago B.; LL-37 immunomodulatory activity during Mycobacterium tuberculosis infection in macrophages. Infect Immun 2015,83(12),4495-4503","journal-title":"Infect Immun"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1084\/jem.192.7.1069","volume":"192","author":"Yang D.","year":"2000","unstructured":"Yang D.; Chen Q.; Schmidt A.P.; Anderson G.M.; Wang J.M.; Wooters J.; Oppenheim J.J.; Chertov O.; LL-37, the neutrophil granule and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 2000,192(7),1069-1074","journal-title":"J Exp Med"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.4049\/jimmunol.172.8.4987","volume":"172","author":"Elssner A.","year":"2004","unstructured":"Elssner A.; Duncan M.; Gavrilin M.; Wewers M.D.; A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J Immunol 2004,172(8),4987-4994","journal-title":"J Immunol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1189\/jlb.0513304","volume":"95","author":"Wan M.","year":"2014","unstructured":"Wan M.; van der Does A.M.; Tang X.; Lindbom L.; Agerberth B.; Haeggstr&#xF6;m J.Z.; Antimicrobial peptide LL-37 promotes bacterial phagocytosis by human macrophages. J Leukoc Biol 2014,95(6),971-981","journal-title":"J Leukoc Biol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev.iy.11.040193.000541","volume":"11","author":"Lehrer R.I.","year":"1993","unstructured":"Lehrer R.I.; Lichtenstein A.K.; Ganz T.; Defensins: Antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 1993,11,105-128","journal-title":"Annu Rev Immunol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0147-9563(03)00105-5","volume":"7","author":"Fu L.M.","year":"2003","unstructured":"Fu L.M.; The potential of human neutrophil peptides in tuberculosis therapy. Int J Tuberc Lung Dis 2003,7(11),1027-1032","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1086\/424463","volume":"190","author":"Kalita A.","year":"2004","unstructured":"Kalita A.; Verma I.; Khuller G.K.; Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy. J Infect Dis 2004,190(8),1476-1480","journal-title":"J Infect Dis"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1128\/AAC.45.2.639-640.2001","volume":"45","author":"Sharma S.","year":"2001","unstructured":"Sharma S.; Verma I.; Khuller G.K.; Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis. Antimicrob Agents Chemother 2001,45(2),639-640","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s00018-005-5540-2","volume":"63","author":"Pazgier M.","year":"2006","unstructured":"Pazgier M.; Hoover D.M.; Yang D.; Lu W.; Lubkowski J.; Human-defensins. Cell Mol Life Sci 2006,63(11),1294-1313","journal-title":"Cell Mol Life Sci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fimmu.2015.00115","volume":"6","author":"Machado L.R.","year":"2015","unstructured":"Machado L.R.; Ottolini B.; An evolutionary history of defensins: A role for copy number variation in maximizing host innate and adaptive immune responses. Front Immunol 2015,6,115","journal-title":"Front Immunol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cellimm.2006.04.001","volume":"239","author":"M&#xE9;ndez-Samperio P.","year":"2006","unstructured":"M&#xE9;ndez-Samperio P.; Miranda E.; Trejo A.; Mycobacterium bovis Bacillus Calmette-Gu&#xE9;rin (BCG) stimulates human-defensin-2 gene transcription in human epithelial cells. Cell Immunol 2006,239(1),61-66","journal-title":"Cell Immunol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"696","DOI":"10.4103\/0366-6999.178011","volume":"129","author":"Zhao Z.","year":"2016","unstructured":"Zhao Z.; Mu Z.L.; Liu X.W.; Liu X.J.; Jia J.; Cai L.; Zhang J.Z.; Expressions of antimicrobial peptides LL-37, human beta defensin-2 and -3 in the lesions of cutaneous tuberculosis and tuberculids. Chin Med J 2016,129(6),696-701","journal-title":"Chin Med J"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2217\/imt.14.119","volume":"7","author":"Rivas-Santiago B.","year":"2015","unstructured":"Rivas-Santiago B.; Rivas-Santiago C.; Sada E.; Hern&#xE1;ndez-Pando R.; Prophylactic potential of defensins and L-isoleucine in tuberculosis household contacts: An experimental model. Immunotherapy 2015,7(3),207-213","journal-title":"Immunotherapy"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1159\/000336619","volume":"4","author":"Semple F.","year":"2012","unstructured":"Semple F.; Dorin, J.R.-Defensins: Multifunctional modulators of infection, inflammation and more? J Innate Immun 2012,4(4),337-348","journal-title":"J Innate Immun"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"865","DOI":"10.4049\/jimmunol.1201648","volume":"191","author":"Tewary P.","year":"2013","unstructured":"Tewary P.; de la Rosa P.; Sharma N.; Rodriguez L.G; Tarasov S.G; Howard O.M.Z.; Shirota H.; Steinhagen F.; Klinman D.M.; Yang D.;  Oppenheim, J.J.-Defensin 2 and 3 promote the uptake of self or CpG DNA, enhance IFN- production by human plasmacytoid dendritic cells, and promote inflammation. J Immunol 2013,191(2),865-874","journal-title":"J Immunol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"7102","DOI":"10.4049\/jimmunol.165.12.7102","volume":"165","author":"Ernst W.A.","year":"2000","unstructured":"Ernst W.A.; Thoma-Uszynski S.; Teitelbaum R.; Ko C.; Hanson D.A.; Clayberger C.; Krensky A.M.; Leippe M.; Bloom B.R.; Ganz T.; Modlin R.L.; Granulysin, a T cell product, kills bacteria by altering membrane permeability. J Immunol 2000,165(12),7102-7108","journal-title":"J Immunol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1189\/jlb.4A0713-363RR","volume":"96","author":"Lu C.C.","year":"2014","unstructured":"Lu C.C.; Wu T.S.; Hsu Y.J.; Chang C.J.; Lin C.S.; Chia J.H.; Wu T.L.; Huang T.T.; Martel J.; Ojcius D.M.; Young J.D.; Lai H.C.; NK cells kill mycobacteria directly by releasing perforin and granulysin. J Leukoc Biol 2014,96(6),1119-1129","journal-title":"J Leukoc Biol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1128\/IAI.00624-07","volume":"75","author":"Andersson J.","year":"2007","unstructured":"Andersson J.; Samarina A.; Fink J.; Rahman S.; Grundstr&#xF6;m S.; Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis. Infect Immun 2007,75(11),5210-5222","journal-title":"Infect Immun"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.tube.2007.01.002","volume":"87","author":"Sahiratmadja E.","year":"2007","unstructured":"Sahiratmadja E.; Alisjahbana B.; Buccheri S.; Di Liberto D.; de Boer T.; Adnan I.; van Crevel R.; Klein M.R.; van Meijgaarden K.E.; Nelwan R.H.H.; van de Vosse E.; Dieli F.; Ottenhoff T.H.M.; Plasma granulysin levels and cellular interferon production correlate with curative host responses in tuberculosis, while plasma interferon- levels correlate with tuberculosis disease activity in adults. Tuberculosis 2007,87(4),312-321","journal-title":"Tuberculosis"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1348-0421.2011.00348.x","volume":"55","author":"Pitabut N.","year":"2011","unstructured":"Pitabut N.; Mahasirimongkol S.; Yanai H.; Ridruechai C.; Sakurada S.; Dhepakson P.; Kantipong P.; Piyaworawong S.; Moolphate S.; Hansudewechakul C.; Yamada N.; Keicho N.; Okada M.; Khusmith S.; Decreased plasma granulysin and increased interferon-gamma concentrations in patients with newly diagnosed and relapsed tuberculosis. Microbiol Immunol 2011,55(8),565-573","journal-title":"Microbiol Immunol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.7150\/ijms.6437","volume":"10","author":"Pitabut N.","year":"2013","unstructured":"Pitabut N.; Sakurada S.; Tanaka T.; Ridruechai C.; Tanuma J.; Aoki T.; Kantipong P.; Piyaworawong S.; Kobayashi N.; Dhepakson P.; Yanai H.; Yamada N.; Oka S.; Okada M.; Khusmith S.; Keicho N.; Potential function of granulysin, other related effector molecules and lymphocyte subsets in patients with TB and HIV\/TB coinfection. Int J Med Sci 2013,10(8),1003-1014","journal-title":"Int J Med Sci"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/j.micinf.2006.02.030","volume":"8","author":"Toro J.C.","year":"2006","unstructured":"Toro J.C.; Hoffner S.; Linde C.; Andersson M.; Andersson J.; Grundstr&#xF6;m S.; Enhanced susceptibility of multidrug resistant strains of Mycobacterium tuberculosis to granulysin peptides correlates with a reduced fitness phenotype. Microbes Infect 2006,8(8),1985-1993","journal-title":"Microbes Infect"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2174\/092986610790963555","volume":"17","author":"Siano A.","year":"2010","unstructured":"Siano A.; Tonarelli G.; Imaz M.; Per&#xED;n J.; Ruggeri N.; L&#xF3;pez M.; Santi M.; Zerbini E.; Bactericidal and hemolytic activities of synthetic peptides derived from granulysin. Protein Pept Lett 2010,17(4),517-521","journal-title":"Protein Pept Lett"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1172\/JCI0215686","volume":"110","author":"Nicolas G.","year":"2002","unstructured":"Nicolas G.; Chauvet C.; Viatte L.; Danan J.L.; Bigard X.; Devaux I.; Beaumont C.; Kahn A.; Vaulont S.; The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002,110(7),1037-1044","journal-title":"J Clin Invest"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1189\/jlb.1208719","volume":"86","author":"Sow F.B.","year":"2009","unstructured":"Sow F.B.; Alvarez G.R.; Gross R.P.; Satoskar A.R.; Schlesinger L.S.; Zwilling B.S.; Lafuse W.P.; Role of STAT1, NFB, and C\/EBP in the macrophage transcriptional regulation of hepcidin by mycobacterial infection and IFN- J Leukoc Biol 2009,86(5),1247-1258","journal-title":"J Leukoc Biol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.tube.2011.03.003","volume":"91","author":"Sow F.B.","year":"2011","unstructured":"Sow F.B.; Nandakumar S.; Velu V.; Kellar K.L.; Schlesinger L.S.; Amara R.R.; Lafuse W.P.; Shinnick T.M.; Sable S.B.; Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin. Tuberculosis 2011,91(4),314-321","journal-title":"Tuberculosis"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/sj.cdd.4401692","volume":"12","author":"Ciechanover A.","year":"2005","unstructured":"Ciechanover A.; Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin\u2013proteasome system and onto human diseases and drug targeting. Cell Death Differ 2005,12(9),1178-1190","journal-title":"Cell Death Differ"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4161\/auto.4272","volume":"3","author":"Purdy G.E.","year":"2007","unstructured":"Purdy G.E.; Russell D.G.; Ubiquitin trafficking to the lysosome: Keeping the house tidy and getting rid of unwanted guests. Autophagy 2007,3(4),399-401","journal-title":"Autophagy"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fmicb.2011.00007","volume":"2","author":"Purdy G.E.","year":"2011","unstructured":"Purdy G.E.; Taking out TB-lysosomal trafficking and mycobactericidal ubiquitin-derived peptides. Front Microbiol 2011,2,7","journal-title":"Front Microbiol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"6031","DOI":"10.1073\/pnas.0700036104","volume":"104","author":"Alonso S.","year":"2007","unstructured":"Alonso S.; Pethe K.; Russell D.G.; Purdy G.E.; Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy. Proc Natl Acad Sci USA 2007,104(14),6031-6036","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1111\/j.1462-5822.2007.01039.x","volume":"9","author":"Purdy G.E.","year":"2007","unstructured":"Purdy G.E.; Russell D.G.; Lysosomal ubiquitin and the demise of Mycobacterium tuberculosis. Cell Microbiol 2007,9(12),2768-2774","journal-title":"Cell Microbiol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/1471-2334-14-355","volume":"14","author":"Samuchiwal S.K.","year":"2014","unstructured":"Samuchiwal S.K.; Tousif S.; Singh D.K.; Kumar A.; Ghosh A.; Bhalla K.; Prakash P.; Kumar S.; Bhattacharyya M.; Moodley P.; Das G.; Ranganathan A.; A peptide fragment from the human COX3 protein disrupts association of Mycobacterium tuberculosis virulence proteins ESAT-6 and CFP10, inhibits mycobacterial growth and mounts protective immune response. BMC Infect Dis 2014,14,355","journal-title":"BMC Infect Dis"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1111\/j.1742-4658.2006.05166.x","volume":"273","author":"Meher A.K.","year":"2006","unstructured":"Meher A.K.; Bal N.C.; Chary K.V.R.; Arora A.; Mycobacterium tuberculosis H37Rv ESAT-6-CFP-10 complex formation confers thermodynamic and biochemical stability. FEBS J 2006,273(7),1445-1462","journal-title":"FEBS J"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.4049\/jimmunol.1002352","volume":"187","author":"Kulig P.","year":"2011","unstructured":"Kulig P.; Kantyka T.; Zabel B.A.; Bana M.; Chyra A.; Stefaska A.; Tu H.; Allen S.J; Handel T.M; Kozik A.; Potempa J.; Butcher E.C; Cichy J.; Regulation of chemerin chemoattractant and antibacterial activity by human cysteine cathepsins. J Immunol 2011,187(3),1403-1410","journal-title":"J Immunol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1074\/jbc.RA118.005495","volume":"294","author":"Godlewska U.","year":"2019","unstructured":"Godlewska U.; Bilska B.; Zegar A.; Brzoza P.; Borek A.; Murzyn K.; Bochenska O.; Morytko A.; Kuleta P.; Kozik A.; Pyza E.; Osyczka A.; Zabel B.A.; Cichy J.; The antimicrobial activity of chemerin-derived peptide p4 requires oxidative conditions. J Biol Chem 2019,294(4),1267-1278","journal-title":"J Biol Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"15349","DOI":"10.1021\/acs.jmedchem.1c01352","volume":"64","author":"Pratap Verma D.","year":"2021","unstructured":"Pratap Verma D.; Ansari M.M.; Verma N.K.; Saroj J.; Akhtar S.; Pant G.; Mitra K.; Singh B.N.; Ghosh J.K.; Tandem repeat of a short human chemerin-derived peptide and its nontoxic d-lysine-containing enantiomer display broad-spectrum antimicrobial and antitubercular activities. J Med Chem 2021,64(20),15349-15366","journal-title":"J Med Chem"},{"key":"ref=79","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2021.0429","author":"Martin A.","year":"2022","unstructured":"Martin A.; Bland M.J.; Rodriguez-Villalobos H.; Gala J.L.; Gabant P.; Promising antimicrobial activity and synergy of bacteriocins against Mycobacterium tuberculosis. Microb Drug Resist 2022","journal-title":"Microb Drug Resist"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ijantimicag.2010.03.029","volume":"36","author":"Carroll J.","year":"2010","unstructured":"Carroll J.; Draper L.A.; O\u2019Connor P.M.; Coffey A.; Hill C.; Ross R.P.; Cotter P.D.; O\u2019Mahony J.; Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria. Int J Antimicrob Agents 2010,36(2),132-136","journal-title":"Int J Antimicrob Agents"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1128\/AAC.49.7.2606-2611.2005","volume":"49","author":"Morgan S.M.","year":"2005","unstructured":"Morgan S.M.; O\u2019Connor P.M.; Cotter P.D.; Ross R.P.; Hill C.; Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations. Antimicrob Agents Chemother 2005,49(7),2606-2611","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1128\/AEM.01827-08","volume":"75","author":"Yoneyama F.","year":"2009","unstructured":"Yoneyama F.; Imura Y.; Ichimasa S.; Fujita K.; Zendo T.; Nakayama J.; Matsuzaki K.; Sonomoto K.; Lacticin Q, a lactococcal bacteriocin, causes high-level membrane permeability in the absence of specific receptors. Appl Environ Microbiol 2009,75(2),538-541","journal-title":"Appl Environ Microbiol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1046\/j.1365-2672.1999.00511.x","volume":"28","author":"Montville T.J.","year":"1999","unstructured":"Montville T.J.; Chung H.J.; Chikindas M.L.; Chen Y.; Nisin A depletes intracellular ATP and acts in bactericidal manner against Mycobacterium smegmatis. Lett Appl Microbiol 1999,28(3),189-193","journal-title":"Lett Appl Microbiol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"408","DOI":"10.4161\/bbug.1.6.13642","volume":"1","author":"Carroll J.","year":"2010","unstructured":"Carroll J.; Field D.; O\u2019 Connor P.M.; Cotter P.D.; Coffey A.; Hill C.; O\u2019 Mahony J.; O\u2019Mahony J.; The gene encoded antimicrobial peptides, a template for the design of novel anti-mycobacterial drugs. Bioeng Bugs 2010,1(6),408-412","journal-title":"Bioeng Bugs"},{"key":"ref=85","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.598789","volume":"11","author":"Karczewski J.","year":"2020","unstructured":"Karczewski J.; Krasucki S.P.; Asare-Okai P.N.; Diehl C.; Friedman A.; Brown C.M.; Maezato Y.; Streatfield S.J.; Isolation, characterization and structure elucidation of a novel lantibiotic from Paenibacillus sp. Front Microbiol 2020,11","journal-title":"Front Microbiol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3389\/fmicb.2018.00415","volume":"9","author":"Kers J.A.","year":"2018","unstructured":"Kers J.A.; Sharp R.E.; Defusco A.W.; Park J.H.; Xu J.; Pulse M.E.; Weiss W.J.; Handfield M.; Mutacin 1140 lantibiotic variants are efficacious against Clostridium difficile infection. Front Microbiol 2018,9,415","journal-title":"Front Microbiol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"12530","DOI":"10.1039\/C9CP01558B","volume":"21","author":"Pokhrel R.","year":"2019","unstructured":"Pokhrel R.; Bhattarai N.; Baral P.; Gerstman B.S.; Park J.H.; Handfield M.; Chapagain P.P.; Molecular mechanisms of pore formation and membrane disruption by the antimicrobial lantibiotic peptide Mutacin 1140. Phys Chem Chem Phys 2019,21(23),12530-12539","journal-title":"Phys Chem Chem Phys"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.chembiol.2014.01.014","volume":"21","author":"Gavrish E.","year":"2014","unstructured":"Gavrish E.; Sit C.S.; Cao S.; Kandror O.; Spoering A.; Peoples A.; Ling L.; Fetterman A.; Hughes D.; Bissell A.; Torrey H.; Akopian T.; Mueller A.; Epstein S.; Goldberg A.; Clardy J.; Lewis K.; Lassomycin, a ribosomally synthesized cyclic peptide, kills Mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2. Chem Biol 2014,21(4),509-518","journal-title":"Chem Biol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1021\/acs.jnatprod.2c00065","volume":"85","author":"Andersen F.D.","year":"2022","unstructured":"Andersen F.D.; Pedersen K.D.; Wilkens Juhl D.; Mygind T.; Chopin P.; B Svenningsen E.; Poulsen T.B; Braad Lund M.; Schramm A.; Gotfredsen C.H; T&#xF8;rring, T. Triculamin: An unusual lasso peptide with potent antimycobacterial activity. J Nat Prod 2022,85(6),1514-1521","journal-title":"J Nat Prod"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/ja.2007.48","volume":"60","author":"Iwatsuki M.","year":"2007","unstructured":"Iwatsuki M.; Uchida R.; Takakusagi Y.; Matsumoto A.; Jiang C.L.; Takahashi Y.; Arai M.; Kobayashi S.; Matsumoto ,M.; Inokoshi J.; Tomoda H.; mura S.;  Lariatins, novel anti-mycobacterial peptides with a lasso structure, produced by Rhodococcus jostii K01-B0171. J Antibiot 2007,60(6),357-363","journal-title":"J Antibiot"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ja.2007.16","volume":"60","author":"Xie Y.","year":"2007","unstructured":"Xie Y.; Chen R.; Si S.; Sun C.; Xu H.; A new nucleosidyl-peptide antibiotic, sansanmycin. J Antibiot 2007,60(2),158-161","journal-title":"J Antibiot"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"14414","DOI":"10.1038\/ncomms14414","volume":"8","author":"Tran A.T.","year":"2017","unstructured":"Tran A.T.; Watson E.E.; Pujari V.; Conroy T.; Dowman L.J.; Giltrap A.M.; Pang A.; Wong W.R.; Linington R.G.; Mahapatra S.; Saunders J.; Charman S.A.; West N.P.; Bugg T.D.; Tod J.; Dowson C.G.; Roper D.I.; Crick D.C.; Britton W.J.; Payne R.J.; Sansanmycin natural product analogues as potent and selective anti-mycobacterials that inhibit lipid I biosynthesis. Nat Commun 2017,8,14414","journal-title":"Nat Commun"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/ja.2008.34","volume":"61","author":"Xie Y.","year":"2008","unstructured":"Xie Y.; Xu H.; Si S.; Sun C.; Chen R.; Sansanmycins B and C, new components of sansanmycins. J Antibiot 2008,61(4),237-240","journal-title":"J Antibiot"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"6804","DOI":"10.1016\/j.bmcl.2011.09.031","volume":"21","author":"Li Y.B.","year":"2011","unstructured":"Li Y.B.; Xie Y.Y.; Du N.N.; Lu Y.; Xu H.Z.; Wang B.; Yu Y.; Liu Y.X.; Song D.Q.; Chen R.X.; Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives. Bioorg Med Chem Lett 2011,21(22),6804-6807","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1021\/np400145u","volume":"76","author":"Cai G.","year":"2013","unstructured":"Cai G.; Napolitano J.G.; McAlpine J.B.; Wang Y.; Jaki B.U.; Suh J.W.; Yang S.H.; Lee I.A.; Franzblau S.G.; Pauli G.F.; Cho S.; Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain. J Nat Prod 2013,76(11),2009-2018","journal-title":"J Nat Prod"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1021\/acs.orglett.0c01110","volume":"22","author":"Hwang S.","year":"2020","unstructured":"Hwang S.; Shin D.; Kim T.H.; An J.S.; Jo S.I.; Jang J.; Hong S.; Shin J.; Oh D.C.; Structural revision of Lydiamycin A by reinvestigation of the stereochemistry. Org Lett 2020,22(10),3855-3859","journal-title":"Org Lett"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/jac\/dkm053","volume":"59","author":"Sosunov V.","year":"2007","unstructured":"Sosunov V.; Mischenko V.; Eruslanov B.; Svetoch E.; Shakina Y.; Stern N.; Majorov K.; Sorokoumova G.; Selishcheva A.; Apt A.; Antimycobacterial activity of bacteriocins and their complexes with liposomes. J Antimicrob Chemother 2007,59(5),919-925","journal-title":"J Antimicrob Chemother"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"e00359","DOI":"10.1128\/AAC.00359-18","volume":"62","author":"Aguilar-P&#xE9;rez C.","year":"2018","unstructured":"Aguilar-P&#xE9;rez C.; Gracia B.; Rodrigues L.; Vitoria A.; Cebri&#xE1;n R.; Deboos&#xE8;re N.; Song O.; Brodin P.; Maqueda M.; A&#xED;nsa J.A.; Synergy between Circular Bacteriocin AS-48 and Ethambutol against Mycobacterium tuberculosis. Antimicrob Agents Chemother 2018,62(9),e00359-e18","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1574-6976.2001.tb00579.x","volume":"25","author":"McAuliffe O.","year":"2001","unstructured":"McAuliffe O.; Ross R.P.; Hill C.; Lantibiotics: Structure, biosynthesis and mode of action. FEMS Microbiol Rev 2001,25(3),285-308","journal-title":"FEMS Microbiol Rev"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1074\/jbc.M006770200","volume":"276","author":"Wiedemann I.","year":"2001","unstructured":"Wiedemann I.; Breukink E.; van Kraaij C.; Kuipers O.P.; Bierbaum G.; de Kruijff B.; Sahl H.G.; Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J Biol Chem 2001,276(3),1772-1779","journal-title":"J Biol Chem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.biotechadv.2016.05.007","volume":"34","author":"Silva J.P.","year":"2016","unstructured":"Silva J.P.; Appelberg R.; Gama F.M.; Antimicrobial peptides as novel anti-tuberculosis therapeutics. Biotechnol Adv 2016,34(5),924-940","journal-title":"Biotechnol Adv"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1039\/c2np20070h","volume":"29","author":"Maksimov M.O.","year":"2012","unstructured":"Maksimov M.O.; Pan S.J.; James Link A.; Lasso peptides Structure.;  function, biosynthesis, and engineering. Nat Prod Rep 2012,29(9),996-1006","journal-title":"Nat Prod Rep"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1007\/s00253-019-09771-6","volume":"103","author":"Zhu S.","year":"2019","unstructured":"Zhu S.; Su Y.; Shams S.; Feng Y.; Tong Y.; Zheng G.; Lassomycin and lariatin lasso peptides as suitable antibiotics for combating mycobacterial infections: current state of biosynthesis and perspectives for production. Appl Microbiol Biotechnol 2019,103(10),3931-3940","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s00018-011-0724-4","volume":"68","author":"S&#xE1;nchez-Hidalgo M.","year":"2011","unstructured":"S&#xE1;nchez-Hidalgo M.; Montalb&#xE1;n-L&#xF3;pez M.; Cebri&#xE1;n R.; Valdivia E.; Mart&#xED;nez-Bueno M.; Maqueda M.; AS-48 bacteriocin: Close to perfection. Cell Mol Life Sci 2011,68(17),2845-2857","journal-title":"Cell Mol Life Sci"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1128\/AAC.05397-11","volume":"56","author":"Sandiford S.","year":"2012","unstructured":"Sandiford S.; Upton M.; Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci. Antimicrob Agents Chemother 2012,56(3),1539-1547","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0022-2836(02)00368-6","volume":"319","author":"Netz D.J.A.","year":"2002","unstructured":"Netz D.J.A.; Pohl R.; Beck-Sickinger A.G.; Selmer T.; Pierik A.J.; Bastos M.C.F.; Sahl H.G.; Biochemical characterisation and genetic analysis of aureocin A53, a new, atypical bacteriocin from Staphylococcus aureus. J Mol Biol 2002,319(3),745-756","journal-title":"J Mol Biol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1016\/j.bmcl.2010.04.100","volume":"20","author":"Pruksakorn P.","year":"2010","unstructured":"Pruksakorn P.; Arai M.; Kotoku N.; Vilch&#xE8;ze C.; Baughn A.D.; Moodley P.; Jacobs W.R.; Kobayashi M.; Trichoderins, novel aminolipopeptides from a marine sponge-derived Trichoderma sp., are active against dormant mycobacteria. Bioorg Med Chem Lett 2010,20(12),3658-3663","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1248\/bpb.34.1287","volume":"34","author":"Pruksakorn P.","year":"2011","unstructured":"Pruksakorn P.; Arai M.; Liu L.; Moodley P.; Jacobs W.R.; Kobayashi M.; Action-mechanism of trichoderin A, an anti-dormant mycobacterial aminolipopeptide from marine sponge-derived Trichoderma sp. Biol Pharm Bull 2011,34(8),1287-1290","journal-title":"Biol Pharm Bull"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nature04051","volume":"437","author":"Mygind P.H.","year":"2005","unstructured":"Mygind P.H.; Fischer R.L.; Schnorr K.M.; Hansen M.T.; S&#xF6;nksen C.P.; Ludvigsen S.; Ravent&#xF3;s D.; Buskov S.; Christensen B.; De Maria L.; Taboureau O.; Yaver D.; Elvig-J&#xF8;rgensen S.G.; S&#xF8;rensen M.V.; Christensen B.E.; Kj&#xE6;rulff S.; Frimodt-Moller N.; Lehrer R.I.; Zasloff M.; Kristensen H.H.; Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 2005,437(7061),975-980","journal-title":"Nature"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.tube.2018.10.008","volume":"113","author":"Tenland E.","year":"2018","unstructured":"Tenland E.; Krishnan N.; Ronnholm A.; Kalsum S.; Puthia M.; Morgelin M.; Davoudi M.; Otrocka M.; Alaridah N.; Glegola-Madejska I.; Sturegard E.; Schmidtchen A.; Lerm M.; Robertson B.D.; Godaly G.; A novel derivative of the fungal antimicrobial peptide plectasin is active against Mycobacterium tuberculosis. Tuberculosis 2018,113,231-238","journal-title":"Tuberculosis"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1021\/ol902553z","volume":"12","author":"Koyama N.","year":"2010","unstructured":"Koyama N.; Kojima S.; Fukuda T.; Nagamitsu T.; Yasuhara T.; O\u0305 mura, S.; Tomoda H.; Structure and total synthesis of fungal calpinactam, a new antimycobacterial agent. Org Lett 2010,12(3),432-435","journal-title":"Org Lett"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/ja.2010.14","volume":"63","author":"Koyama N.","year":"2010","unstructured":"Koyama N.; Kojima s.; Nonaka k.; Masuma R.; Matsumoto M.; mura S.; Tomoda H.;  Calpinactam, a new anti-mycobacterial agent, produced by Mortierella alpina FKI-4905. J Antibiot 2010,63(4),183-186","journal-title":"J Antibiot"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1096\/fj.13-227454","volume":"27","author":"Wei L.","year":"2013","unstructured":"Wei L.; Wu J.; Liu H.; Yang H.; Rong M.; Li D.; Zhang P.; Han J.; Lai R.; A mycobacteriophage ;derived trehalose-6,6 dimycolate binding peptide containing both antimycobacterial and anti inflammatory abilities. FASEB J 2013,27(8),3067-3077","journal-title":"FASEB J"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/jac\/47.5.575","volume":"47","author":"Linde C.M.A.","year":"2001","unstructured":"Linde C.M.A.; Hoffner S.E.; Refai E.; Andersson M.; In vitro activity of PR-39, a proline-arginine-rich peptide, against susceptible and multi-drug-resistant Mycobacterium tuberculosis. J Antimicrob Chemother 2001,47(5),575-580","journal-title":"J Antimicrob Chemother"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1128\/iai.61.7.2978-2984.1993","volume":"61","author":"Boman H.G.","year":"1993","unstructured":"Boman H.G.; Agerberth B.; Boman A.; Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun 1993,61(7),2978-2984","journal-title":"Infect Immun"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1128\/iai.64.3.926-932.1996","volume":"64","author":"Miyakawa Y.","year":"1996","unstructured":"Miyakawa Y.; Ratnakar P.; Rao A.G.; Costello M.L.; Mathieu-Costello O.; Lehrer R.I.; Catanzaro A.; In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis. Infect Immun 1996,64(3),926-932","journal-title":"Infect Immun"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1099\/jmm.0.000912","volume":"68","author":"Portell-Buj E.","year":"2019","unstructured":"Portell-Buj E.; Vergara A.; Alejo I.; L&#xF3;pez-Gav&#xED;n A.; Mont&#xE9; M.R.; San Nicol&#xE1;s L.; Gonz&#xE1;lez-Mart&#xED;n J.; Tud&#xF3; G.; In vitro activity of 12 antimicrobial peptides against Mycobacterium tuberculosis and Mycobacterium avium clinical isolates. J Med Microbiol 2019,68(2),211-215","journal-title":"J Med Microbiol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"10957","DOI":"10.1007\/s11033-012-1997-x","volume":"39","year":"2012","unstructured":"Cathelicidins: Family of antimicrobial peptides. A review. Mol Biol Rep 2012,39(12),10957-10970","journal-title":"Mol Biol Rep"},{"key":"ref=119","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2020.170373","volume":"132","author":"Abraham P.","year":"2020","unstructured":"Abraham P.; Jose L.; Maliekal T.T.; Kumar R.A.; Kumar K.S.; B1CTcu5: A frog-derived brevinin-1 peptide with anti-tuberculosis activity. Peptides 2020,132","journal-title":"Peptides"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0924-8579(03)00110-9","volume":"22","author":"Xie J.P.","year":"2003","unstructured":"Xie J.P.; Yue J.; Xiong Y.L.; Wang W.Y.; Yu S.Q.; Wang H.H.; In vitro activities of small peptides from snake venom against clinical isolates of drug-resistant Mycobacterium tuberculosis. Int J Antimicrob Agents 2003,22(2),172-174","journal-title":"Int J Antimicrob Agents"},{"key":"ref=121","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2022.183895","volume":"1864","author":"Priya A.","year":"2022","unstructured":"Priya A.; Aditya A.; Budagavi D.P.; Chugh A.; Tachyplesin and CyLoP-1 as efficient anti-mycobacterial peptides: A novel finding. Biochim Biophys Acta Biomembr 2022,1864(7)","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.micres.2014.08.012","volume":"170","author":"Hong J.","year":"2015","unstructured":"Hong J.; Guan W.; Jin G.; Zhao H.; Jiang X.; Dai J.; Mechanism of tachyplesin I injury to bacterial membranes and intracellular enzymes, determined by laser confocal scanning microscopy and flow cytometry. Microbiol Res 2015,170,69-77","journal-title":"Microbiol Res"},{"key":"ref=123","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101742","volume":"9","author":"Rodr&#xED;guez A.","year":"2014","unstructured":"Rodr&#xED;guez A.; Villegas E.; Montoya-Rosales A.; Rivas-Santiago B.; Corzo G.; Characterization of antibacterial and hemolytic activity of synthetic pandinin 2 variants and their inhibition against Mycobacterium tuberculosis. PLoS One 2014,9(7)","journal-title":"PLoS One"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.peptides.2015.08.014","volume":"73","author":"Ramirez-Carreto S.","year":"2015","unstructured":"Ramirez-Carreto S.; Jimenez-Vargas J.M.; Rivas-Santiago B.; Corzo G.; Possani L.D.; Becerril B.; Ortiz E.; Peptides from the scorpion Vaejovis punctatus with broad antimicrobial activity. Peptides 2015,73,51-59","journal-title":"Peptides"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s12602-020-09647-6","volume":"12","author":"da Silva G.R.","year":"2020","unstructured":"da Silva G.R.; Taveira G.B.; de Azevedo dos S.L; Calixto S.D; Sim&#xE3;o T.L.B.V.; Lassounskaia E.; Muzitano M.F.; Teixeira-Ferreira A.; Perales J.; Rodrigues R.; de Oliveira C.A; Gomes V.M;  Identification and characterization of two defensins from Capsicum annuum fruits that exhibit antimicrobial activity. Probiotics Antimicrob Proteins 2020,12(3),1253-1265","journal-title":"Probiotics Antimicrob Proteins"},{"key":"ref=126","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2021.170626","volume":"145","author":"Henao A.D.C.","year":"2021","unstructured":"Henao A.D.C.; Toro L.J.; Tellez R.G.A.; Osorio-Mendez J.F.; Rodriguez-Carlos A.; Valle J.; Marin-Luevano S.P.; Rivas-Santiago B.; Andreu D.; Castano O.J.C.; Novel antimicrobial cecropins derived from O. curvicornis and D. satanas dung beetles. Peptides 2021,145","journal-title":"Peptides"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/jlb.56.6.807","volume":"56","author":"Shi J.","year":"1994","unstructured":"Shi J.; Ross C.R.; Chengappa M.M.; Blecha F.; Identification of a proline-arginine-rich antibacterial peptide from neutrophils that is analogous to PR-39, an antibacterial peptide from the small intestine. J Leukoc Biol 1994,56(6),807-811","journal-title":"J Leukoc Biol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40529-021-00312-x","volume":"62","author":"Li J.","year":"2021","unstructured":"Li J.; Hu S.; Jian W.; Xie C.; Yang X.; Plant antimicrobial peptides: Structures, functions, and applications. Bot Stud 2021,62(1),5","journal-title":"Bot Stud"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.2174\/0929867324666170526120218","volume":"24","author":"Chowanski S.","year":"2017","unstructured":"Chowanski S.; Adamski Z.; Lubawy J.; Marciniak P.; Pacholska-Bogalska J.; Slocinska M.; Spochacz M.; Szymczak M.; Urbanski A.; Walkowiak-Nowicka K.; Rosinski G.; Insect peptides - perspectives in human diseases treatment. Curr Med Chem 2017,24(29),3116-3152","journal-title":"Curr Med Chem"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1128\/AAC.01667-10","volume":"55","author":"Kapoor R.","year":"2011","unstructured":"Kapoor R.; Eimerman P.R.; Hardy J.W.; Cirillo J.D.; Contag C.H.; Barron A.E.; Efficacy of antimicrobial peptoids against Mycobacterium tuberculosis. Antimicrob Agents Chemother 2011,55(6),3058-3062","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/j.biomaterials.2013.11.035","volume":"35","author":"Khara J.S.","year":"2014","unstructured":"Khara J.S.; Wang Y.; Ke X.Y.; Liu S.; Newton S.M.; Langford P.R.; Yang Y.Y.; Ee P.L.R.; Anti-mycobacterial activities of synthetic cationic -helical peptides and their synergism with rifampicin. Biomaterials 2014,35(6),2032-2038","journal-title":"Biomaterials"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.tube.2014.08.001","volume":"94","author":"Lan Y.","year":"2014","unstructured":"Lan Y.; Lam J.T.; Siu G.K.H.; Yam W.C.; Mason A.J.; Lam J.K.W.; Cationic amphipathic D-enantiomeric antimicrobial peptides with in vitro and ex vivo activity against drug-resistant Mycobacterium tuberculosis. Tuberculosis 2014,94(6),678-689","journal-title":"Tuberculosis"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1016\/j.bmc.2016.06.048","volume":"24","author":"Hicks R.P.","year":"2016","unstructured":"Hicks R.P.; Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C amino acids. Bioorg Med Chem 2016,24(18),4056-4065","journal-title":"Bioorg Med Chem"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"64","DOI":"10.31083\/j.fbl2702064","volume":"27","author":"Fleck B.S.","year":"2022","unstructured":"Fleck B.S.; Mukherjee D.; Tram N.D.T.; Ee P.L.R.; Schepers U.; Novel tetrameric cell penetrating antimicrobial peptoids effective against mycobacteria and drug-resistant Staphylococcus aureus. Front Biosci Landmark 2022,27(2),64","journal-title":"Front Biosci Landmark"},{"key":"ref=135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040125","volume":"7","author":"Rodr&#xED;guez Plaza J.G.","year":"2012","unstructured":"Rodr&#xED;guez Plaza J.G.; Villal&#xF3;n Rojas A.; Herrera S.; Garza-Ramos G.; Torres Larios A.; Amero C.; Zarraga Granados G.; Guti&#xE9;rrez Aguilar M.; Lara Ortiz M.T.; Polanco Gonzalez C.; Uribe Carvajal S.; Coria R.; Pe&#xF1;a D&#xED;az A.; Bredesen D.E.; Castro-Obregon S.; del Rio G.; Moonlighting peptides with emerging function. PLoS One 2012,7(7)","journal-title":"PLoS One"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3390\/pharmaceutics12111071","volume":"12","author":"Pel&#xE1;ez Coyotl E.A.","year":"2020","unstructured":"Pel&#xE1;ez Coyotl E.A.; Barrios Palacios J.; Muci&#xF1;o G.; Moreno-Blas D.; Costas M.; Montiel Montes T.; Diener C.; Uribe-Carvajal S.; Massieu L.; Castro-Obreg&#xF3;n S.; Espinosa O.R.; Mata Espinosa D.; Barrios-Payan J.; Le&#xF3;n Contreras J.C.; Corzo G.; Hern&#xE1;ndez-Pando R.; Del Rio G.; Antimicrobial peptide against Mycobacterium tuberculosis that activates autophagy is an effective treatment for tuberculosis. Pharmaceutics 2020,12(11),1071","journal-title":"Pharmaceutics"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1128\/AAC.00940-15","volume":"60","author":"Pearson C.S.","year":"2016","unstructured":"Pearson C.S.; Kloos Z.; Murray B.; Tabe E.; Gupta M.; Kwak J.H.; Karande P.; McDonough K.A.; Belfort G.; Combined bioinformatic and rational design approach to develop antimicrobial peptides against Mycobacterium tuberculosis. Antimicrob Agents Chemother 2016,60(5),2757-2764","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41551-020-00665-x","volume":"5","author":"Simonson A.W.","year":"2021","unstructured":"Simonson A.W.; Mongia A.S.; Aronson M.R.; Alumasa J.N.; Chan D.C.; Lawanprasert A.; Howe M.D.; Bolotsky A.; Mal T.K.; George C.; Ebrahimi A.; Baughn A.D.; Proctor E.A.; Keiler K.C.; Medina S.H.; Pathogen-specific antimicrobials engineered de novo through membrane-protein biomimicry. Nat Biomed Eng 2021,5(5),467-480","journal-title":"Nat Biomed Eng"},{"key":"ref=139","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202100453","volume":"10","author":"Beitzinger B.","year":"2021","unstructured":"Beitzinger B.; Gerbl F.; Vomhof T.; Schmid R.; Noschka R.; Rodriguez A.; Wiese S.; Weidinger G.; St&#xE4;ndker L.; Walther P.; Michaelis J.; Lind&#xE9;n M.; Stenger S.; Delivery by dendritic mesoporous silica nanoparticles enhances the antimicrobial activity of a napsin-derived peptide against intracellular Mycobacterium tuberculosis. Adv Healthc Mater 2021,10(14)","journal-title":"Adv Healthc Mater"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/978-981-13-3588-4_15","volume":"1117","author":"Costa F.","year":"2019","unstructured":"Costa F.; Teixeira C.; Gomes P.; Martins M.C.L.; Clinical application of AMPs. Adv Exp Med Biol 2019,1117,281-298","journal-title":"Adv Exp Med Biol"},{"key":"ref=141","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212858","volume":"14","author":"Tenland E.","year":"2019","unstructured":"Tenland E.; Pochert A.; Krishnan N.; Umashankar Rao K.; Kalsum S.; Braun K.; Glegola-Madejska I.; Lerm M.; Robertson B.D.; Lind&#xE9;n M.; Godaly G.; Effective delivery of the anti-mycobacterial peptide NZX in mesoporous silica nanoparticles. PLoS One 2019,14(2)","journal-title":"PLoS One"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.pep.2017.08.003","volume":"140","author":"Deng T.","year":"2017","unstructured":"Deng T.; Ge H.; He H.; Liu Y.; Zhai C.; Feng L.; Yi L.; The heterologous expression strategies of antimicrobial peptides in microbial systems. Protein Expr Purif 2017,140,52-59","journal-title":"Protein Expr Purif"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3390\/antibiotics10080898","volume":"10","author":"Mirzaee M.","year":"2021","unstructured":"Mirzaee M.; Hol&#xE1;skov&#xE1; E.; Mi&#xFA;chov&#xE1; A.; Kopen&#xFD; D.J.; Osmani Z.; Fr&#xE9;bort I.; Long-lasting stable expression of human LL-37 antimicrobial peptide in transgenic barley plants. Antibiotics 2021,10(8),898","journal-title":"Antibiotics"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929866530666230315113624","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/214642\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929866530666230315113624","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T15:07:02Z","timestamp":1691334422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/214642\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":143,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929866530666230315113624","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-12-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}